COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 194: Articles 1931-1940  | Next

Brain-heart interactions are associated with mortality and acute encephalopathy in ICU patients with severe COVID-19
Hermann, B., Benghanem, S., Pruvost-Robieux, E., Sharshar, T., Gavaret, M., Cariou, A., Diehl, J.-L., Candia-Rivera, D.
10.1101/2024.10.01.24314706 — Posted: 2024-10-01
Teicoplanin attenuates RNA virus infection in vitro
Espano, E., Kim, J., Park, S. O., Padasas, B. T., Kim, S.-H., Son, J.-H., Oh, J., Woo, E.-E., Lee, Y.-R., Hwang, S. Y., Eo, S. K., Kim, J.-K.
10.1101/2024.09.29.615295 — Posted: 2024-10-01
Cxcl10 is required for survival during SARS-CoV-2 infection in mice
Majumdar, S., Weaver, J. D., Pontejo, S. M., Mahnaz, M., Lu, X., Gao, J.-L., Holmes, G., Johnson, R., Zhang, H., Kelsall, B. L., Farber, J. M., Alves, D. A., Murphy, P. M.
10.1101/2024.09.30.613319 — Posted: 2024-10-01
Design of nanobody targeting SARS-CoV-2 spike glycoprotein using CDR-grafting assisted by molecular simulation and machine learning
Ferraz, M. V. F., Adan, W. C. S., Lima, T. E., Santos, A. J. C., de Paula, S. O., Dhalia, R., Wallau, G. L., Wade, R. C., Viana, I. F. T., Lins, R. D.
10.1101/2024.09.30.615772 — Posted: 2024-10-01
SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions
Tort, L. F., de Araujo, M. F., Arantes, I., MARTINS, J. S., Gomes, M. F., de Carvalho, F. C., de Almeida, W. A., Caetano, B. C., Appolinario, L. R., Pereira, E. C., Carvalho, J. G., Miyajima, F. F. C., Wallau, G. L., Naveca, F. G., Alves, P., Espindola, O., Brasil, P., Resende, P. C., Bello, G., Siqueira, M. M.
10.1101/2024.09.28.24314453 — Posted: 2024-09-30
Gut colonization of Enterococcus species is associated with COVID-19 disease in Uganda
Agudelo, C., Kateete, D. P., Nasinghe, E., Kamulegeya, R., Lubega, C., Mbabazi, M. M., Baker, N., Lin, K., Liu, C. C., Kasambula, A. S., Kigozi, E., Komakech, K., Mukisa, J., Mulumba, K., Mwachan, P., Nakalanda, B. S., Nalubega, G. P., Nsubuga, J., Sitenda, D., Ssenfuka, H., Cirolia, G., Gustafson, J. T., Wang, R., Nsubuga, M. L., Yiga, F., Stanley, S. A., Bagaya, B. S., Elliott, A., Joloba, M., Wolf, A. R.
10.1101/2024.09.28.24314457 — Posted: 2024-09-30
Predicting Mobile Health Clinic Utilization for COVID-19 Vaccination in South Carolina: A Statistical Framework for Strategic Resource Allocation
Gezer, F., Howard, K. A., Bennett, K. J., Litwin, A. H., Sease, K. K., Rennert, L.
10.1101/2024.09.27.24314475 — Posted: 2024-09-29
Common pathogenic mechanisms for COVID-19 and differentiated thyroid cancer: a proteomic analysis
Liu, H., Wang, J., Yang, D., Chen, C.
10.1101/2024.09.28.24314528 — Posted: 2024-09-29
Comparative evaluation of cell-based assay technologies for scoring drug-induced condensation of SARS-CoV-2 nucleocapsid protein
Quek, R. T., Shirazinejad, C. R., Young, C. L., Hardy, K. S., Lim, S., Elms, P. J., McSwiggen, D. T., Mitchison, T. J., Silver, P. A.
10.1101/2024.09.26.615262 — Posted: 2024-09-28
The post-pandemic hospital and mortality burden of COVID-19 compared with influenza: A national cohort study in Denmark, May 2022 to June 2024
Bager, P., Bech Svalgaard, I., Kristensen Lomholt, F., Emborg, H.-D., Engbo Christiansen, L., Soborg, B., Hviid, A., Skafte Vestergaard, L.
10.1101/2024.09.26.24314428 — Posted: 2024-09-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).